<DOC>
	<DOCNO>NCT01247779</DOCNO>
	<brief_summary>The purpose study compare perioperative morbidity coelioscopy versus robot-assisted coelioscopy cervical cancer , uterus cancer ovarian cancer .</brief_summary>
	<brief_title>Perioperative Morbidity Gyneco-oncology According Procedure : Coelioscopy Versus Robot-assisted Coelioscopy</brief_title>
	<detailed_description>Laparoscopic surgery , also call minimally invasive surgery ( MIS ) , surgical method less invasive classical laparoscopic open procedure . Particularly , MIS use resection gynecological cancer endometrial cancer , cervical cancer ovarian cancer . Several study demonstrate MIS induce le surgical complication ( bleed , infection , post-operative pain ... ) , short hospitalization time , early recovery activity well quality life laparoscopic open procedure . However , MIS select method 9 25 % gynecologic cancer surgery France . This likely due long learn curve MIS compare laparoscopic open procedure . In 2001 FDA allow use robot assist laparoscopic surgery ( RALS ) . This technique add advantage laparoscopic surgery . Indeed , surgeon operate good precision seat comfortably computer console view 3-D image surgical field . Moreover learn curve RALS shorter MIS . Comparative study RALS MIS demonstrate equivalence technique operation length bleeding . However surgery link complication time recovery activity , RALS good result MIS . Despite expensive cost , RALS commonly use North America ( 90 % prostatectomy 40 % cancer link hysterectomy ) . However RALS need evaluate randomized clinical trial 's acceptation gyneco-oncology France . Thus , purpose ROBOGYN clinical trial compare clinical benefit RALS MIS randomize study patient cancer cervix , uterus ovary .</detailed_description>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Uterine Neoplasms</mesh_term>
	<criteria>patient uterus cancer depend hysterectomy ± pelvic lymphadenectomy restadification patient cervical cancer depend enlarge colpohysterectomy ± pelvic lymphadenectomy surgery concomitant radiochemotherapy , lombo aortic lymphadenectomy locally advanced cancer , restadification patient cervical cancer depend restadification patient age 18 year previous antitumor treatment allow necessarily disrupt 20 day inclusion WHO score equal inferior 3 cirrhosisrelated ChildPugh score equal A7 allow life expectancy equal superior 12 week patient affiliate health insurance date sign informed consent metastatic disease pregnant breastfeed woman patient unable proceed followup visit , geographic , social mental reason</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>gynecology</keyword>
	<keyword>oncology</keyword>
	<keyword>coelioscopy</keyword>
	<keyword>robot</keyword>
	<keyword>morbidity</keyword>
</DOC>